Rua Life Sciences PLC (RUA) — Strategic Asset Allocation Index
Rua Life Sciences PLC (RUA) has a Strategic Asset Allocation Index of 46.4% as of September 2022. Strategic assets (PP&E of GBX2.54 Million plus long-term investments of GBX-) total GBX2.54 Million, measured against net assets of GBX5.49 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Rua Life Sciences PLC to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Rua Life Sciences PLC Strategic Asset Allocation Index (2019–2022)
This chart shows how Rua Life Sciences PLC's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2022, the index stands at 46.4%, representing strategic assets of GBX2.54 Million against net assets of GBX5.49 Million GBX. For live market cap and overall valuation, see market value of Rua Life Sciences PLC.
Annual Strategic Asset Allocation Index for Rua Life Sciences PLC (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Rua Life Sciences PLC from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Rua Life Sciences PLC (RUA) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (GBX) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 39.4% | GBX2.60 Million | GBX2.60 Million | GBX- | GBX6.58 Million | ▲ +16.5 pp |
| 2021 | 22.9% | GBX1.95 Million | GBX1.95 Million | GBX- | GBX8.51 Million | ▲ +22.7 pp |
| 2020 | 0.2% | GBX5.00K | GBX5.00K | GBX- | GBX2.27 Million | ▲ +0.2 pp |
| 2019 | 0.0% | GBX1.00K | GBX1.00K | GBX- | GBX3.00 Million | — |